Literature DB >> 14737036

Nitric oxide modulates microglial activation.

George B Stefano1, Ellen Kim, Yu Liu, Wei Zhu, Federico Casares, Kirk Mantione, Dolisha A Jones, Patrick Cadet.   

Abstract

BACKGROUND: Nitric oxide (NO) has important physiological regulatory roles, i.e, vasodilation, neurotransmitter release, etc. Little is known about the processes in neural tissues, which stabilize microglia. This study attempts to answer this question by demonstrating a role for basal NO in maintaining microglia juxtaposed to neurons. MATERIAL/
METHODS: Mytilus edulis (a marine bivalve), were used to examine microglia egress from excised pedal ganglia microscopically. Nitric oxide is measured in excised pedal ganglia amperometrically in real-time.
RESULTS: Pedal ganglia exhibit basal NO release (1 nM range). Inhibition of basal NO release by L-NAME results in greater numbers of microglia in the incubation medium. This process appears to involve two phases of egress. The first involves a slow egress of microglia, whereas the second, occurring 18 hours later, involves a more rapid release of these cells. Low levels of the NO donor SNAP (1 nM) does not interrupt microglial egress, whereas in the presence of L-NAME it does. Exposing the ganglia to high NO levels for a short period of time inhibits their egress.
CONCLUSIONS: Spontaneous ganglionic NO release maintains/stabilizes microglia juxtaposed to neurons. Excised ganglia at the various observation periods reveals a transition of constitutive nitric oxide synthase (NOS) to inducible NOS derived NO. It also appears that the microglia in some unknown manner become insensitive to iNOS derived NO since they exhibit enhanced migration during this last phase of the ganglionic NO response. Taken together, NO is involved with regulating microglial activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14737036

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Authors:  Sara Ahmed; Yu Jing; Bruce G Mockett; Hu Zhang; Wickliffe C Abraham; Ping Liu
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 2.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 3.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 4.  Hypoxia defined as a common culprit/initiation factor in mitochondrial-mediated proinflammatory processes.

Authors:  George B Stefano; Richard M Kream
Journal:  Med Sci Monit       Date:  2015-05-22

5.  Neuroprotective Role of L-NG-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like Behaviour.

Authors:  Satya Narayan Deep; Iswar Baitharu; Apurva Sharma; Anoop Kishor Singh Gurjar; Dipti Prasad; Shashi Bala Singh
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

6.  Dysregulation of Nitric Oxide Signaling in Microglia: Multiple Points of Functional Convergence in the Complex Pathophysiology of Alzheimer Disease.

Authors:  George B Stefano; Tobias Esch; Radek Ptacek; Richard M Kream
Journal:  Med Sci Monit       Date:  2020-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.